ENGERIX-B 20 MCG / 1 ML
HEPATITIS B SURFACE ANTIGEN (RECOMBINANT) : 20 MCG / 1 ML · DIN 01919431 · GLAXOSMITHKLINE INC
Health Canada status: CANCELLED POST MARKET
What is ENGERIX-B?
ENGERIX-B 20 MCG / 1 ML contains HEPATITIS B SURFACE ANTIGEN (RECOMBINANT) : 20 MCG / 1 ML. It is listed in the Health Canada Drug Product Database under DIN 01919431, held by GLAXOSMITHKLINE INC, supplied as SUSPENSION for INTRAMUSCULAR administration. Health Canada currently lists it as cancelled post market, status dated 26-May-2020. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
Product details and regulatory record
| DIN | 01919431 |
|---|---|
| Brand name | ENGERIX-B |
| Generic / active ingredient | HEPATITIS B SURFACE ANTIGEN (RECOMBINANT) : 20 MCG / 1 ML |
| Manufacturer | GLAXOSMITHKLINE INC |
| Strength | 20 MCG / 1 ML |
| Dosage form | SUSPENSION |
| Route of administration | INTRAMUSCULAR |
| Schedule | Schedule D |
| ATC code | J07BC01 HEPATITIS B, PURIFIED ANTIGEN |
| Biosimilar | No |
| Health Canada status | CANCELLED POST MARKET |
| Status date | 26-May-2020 |
What can be used instead?
Other Canadian products sharing ATC code J07BC01 HEPATITIS B, PURIFIED ANTIGEN. 3 of 9 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.
| Product | Strength | Form | Manufacturer | Health Canada status | DIN |
|---|---|---|---|---|---|
| ENGERIX-B | 10 MCG / 0.5 ML | SUSPENSION | GLAXOSMITHKLINE INC | MARKETED | DIN 02487020 |
| ENGERIX-B | 20 MCG / 1 ML | SUSPENSION | GLAXOSMITHKLINE INC | MARKETED | DIN 02487039 |
| RECOMBIVAX HB | 40 MCG | SUSPENSION | MERCK CANADA INC | MARKETED | DIN 02245977 |
| ENGERIX-B | 10 MCG / 0.5 ML | SUSPENSION | GLAXOSMITHKLINE INC | CANCELLED POST MARKET | DIN 02296454 |
| PREHEVBRIO | 10 MCG | SUSPENSION | VBI VACCINES INC. | APPROVED | DIN 02533286 |
| RECOMBIVAX HB | 10 MCG | SUSPENSION | MERCK CANADA INC | CANCELLED POST MARKET | DIN 02243676 |
| RECOMBIVAX HB (ADULT DIALYSIS WITH PRESERVATIVE) | 40 MCG | SOLUTION | MERCK CANADA INC | CANCELLED POST MARKET | DIN 01934023 |
| RECOMBIVAX HB (WITH PRESERVATIVE) | 10 MCG | SOLUTION | MERCK CANADA INC | CANCELLED POST MARKET | DIN 00749486 |
Who else supplies HEPATITIS B, PURIFIED ANTIGEN worldwide?
Nexara tracks national medicine registries and published price lists across multiple markets. HEPATITIS B, PURIFIED ANTIGEN appears in 66 registered pack listings across 8 markets, published on 6 different national price bases. Where a Canadian route is closed, that is where an alternative route of supply starts — subject to the import rules in both countries.
Registered listings are not stock. Ask us to confirm what can actually be sourced for your order.
Can this still be bought in Canada?
No. This Drug Identification Number is cancelled post market in Health Canada's Drug Product Database, so the product is no longer authorized for sale in Canada and Nexara does not supply it. This page is kept as a regulatory record.
If you are looking for a current equivalent, the alternatives above list every product sharing this therapeutic class, with the marketed ones first. Ask us to source an alternative
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.